Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit growth in Established ...
Full year sales growth guidance was raised to a range of 9% to 11% from the previous 6% to 8%, reflecting strong currency performance, especially in SAT, partially offset by a reduced sales outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback